Since MEK can upregulate c-Maf expression through the FOS transcription factor, targeting the MEK/ERK pathway by treatment with two typical MEK inhibitors U0126 and AZD6244 and a novel MEK inhibitor AS703026 inhibits MM proliferation and induces MM cell apoptosis [62, 206]. This evidence concerns the gene MAP2K7 and Miyoshi myopathy.